Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese researchers discover new SST2 receptor ligands

Jan. 28, 2022

Bacainn Therapeutics synthesizes new NLRP inflammasome inhibitors

Jan. 28, 2022

Gilgamesh Pharmaceuticals identifies new 5-HT2A receptor agonists

Jan. 28, 2022

BridGene Biosciences divulges YAP1/TEAD interaction inhibitors

Jan. 28, 2022

Pfizer patents new JAK inhibitors

Jan. 28, 2022

Beta-elemene NO derivatives demonstrate potent antiglioma activity in vivo

Jan. 28, 2022

Novel nonviral engineered BAFF-CAR T cells show efficacy in multiple B-cell cancer models

Jan. 28, 2022

Sophoridine derivatives show improved potency against triple-negative breast cancer

Jan. 28, 2022

Loperamide shows antitumoral activity in TET2-mutated AML

Jan. 28, 2022

Low penetrance of deleterious genetic variants observed in large cohorts

Jan. 28, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...